Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100
Albumax Has Been Approved by Medicaid in California & Pennsylvania
| Source: Medivisor, Inc.
HUNTINGTON STATION, NY--(Marketwire - September 25, 2008) - Medivisor, Inc. (PINKSHEETS : MVSR )
announced today that Albumax has been approved by the California and the
Pennsylvania State Medicaid Offices. Albumax has previously received
approval from the New York State Medicaid Office. Albumax has been
approved under code B4155 as an enteral product. This approval allows for
Medicaid reimbursement of costs for eligible patients using Albumax.
Medicaid is the largest source of funding for medical and health-related
services for people with limited income. It is an entitlement program that
is jointly funded by the states and federal government, and is managed by
the states. Among the groups of people served by Medicaid are eligible
low-income parents, children, seniors, and people with disabilities.
"These additional Medicaid approvals are extremely important for the
national rollout of Albumax," said Mr. Dino Luzzi, CEO of Medivisor, Inc.
"Medicaid acceptance for Albumax increases the willingness of providers and
patients to use Albumax to increase blood albumin levels in kidney disorder
patients," continued Mr. Luzzi. Patients and those in the Medical
Profession can now go to www.albumax.net to order or inquire about the
product.
About Medivisor, Inc.:
Medivisor, Inc. is a developer of next-generation focus driven marketing
tools, dedicated to providing technologies that offer innovative and
competitive advantages to the bioscience and pharmaceutical markets. From
pre-product development through product launch and commercialization,
Medivisor offers worldwide experience in delivering effective and
successful integrated marketing and creative communications campaigns for
the benefit of its clients.
Safe Harbor
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act").
Additionally, words such as "seek," "intend," "believe," "plan,"
"estimate," "expect," "anticipate" and other similar expressions are
forward-looking statements within the meaning of the Act. Some or all of
the events or results anticipated by these forward-looking statements may
not occur. Further information on Medivisor risk factors is contained in
its filings with the Securities and Exchange Commission. Medivisor does not
undertake any duty nor does it intend to update the results of these
forward-looking statements.